Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?
about
Everolimus-eluting stents in interventional cardiologySirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.Bioresorbable scaffolds: a new paradigm in percutaneous coronary interventionBioresorbable scaffolds: current evidence and ongoing clinical trialsOptical coherence tomography: from research to practiceRecent advances in drug eluting stentsNanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteriesThe Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical EvidenceVery late thrombosis after implantation of sirolimus eluting stentLate acute thrombosis after implantation of sirolimus-eluting stent to treat in-stent restenosisDrug-eluting stent: a review and updateNeointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomographyEffects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placementSafety and efficacy of biodegradable drug-eluting vs. bare metal stents: a meta-analysis from randomized trialsAssociation of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosisCan Platforms Affect the Safety and Efficacy of Drug-Eluting Stents in the Era of Biodegradable Polymers?: A Meta-Analysis of 34,850 Randomized IndividualsMacromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary interventionAdvances in stent technologies and their effect on clinical efficacy and safetyCoronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and TreatmentApplications of optical coherence tomography in cardiovascular medicine, Part 2Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenariosExperience with biodegradable polymer coated sirolimus-eluting coronary stent system in "real-life" percutaneous coronary intervention: 24-month data from the manipal-s registryBiodegradable Cable-Tie Rapamycin-eluting Stents.Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data RegistryOne-year outcomes following drug-eluting balloon use for coronary ostial restenosis.Clinical use of optical coherence tomography to identify angiographic silent stent thrombosisGenous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study.Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Miniaturized self-expanding drug-eluting stent in small coronary arteries: late effectiveness.A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy.Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort.Drug-eluting stentsBiodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomizeIn-stent restenosis exacerbated by drug-induced severe eosinophilia after second-generation drug-eluting stent implantation.Modeling and analysis of drug-eluting stents with biodegradable PLGA coating: consequences on intravascular drug deliveryA randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with CoronarPaclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stentsA prospective, multi-centric, observational registry to evaluate performance of Excel™ DES in 'real world, all comers' patient population.
P2860
Q24630321-11EC7544-5027-4D38-8A91-514DC5D63E2FQ24815293-3F082088-FAA3-41A5-8D5B-F116DE00D4B5Q26766579-843456BA-4E5A-4D60-8A81-3BDE663FDAF6Q26863627-D8B6141F-38B2-4CD0-9FB6-AD1D46206B68Q26991471-BCF74B91-0323-40FF-A5DD-52199DD5F3ABQ27025538-A22106DD-F196-4C37-A514-D5AD1A054AD2Q27329486-EBC6F9F1-AAFF-445F-95F2-39E4F6398D35Q28067509-A2450BCE-C189-4538-96A0-1EDF898E328BQ28175480-10406E45-6F61-49D1-A631-9C42AA341995Q28199944-B1E8B67B-08FB-454B-99C8-4C1F77AE7C2DQ28219254-64794396-DA94-491F-830A-6D3139353A12Q28222520-CDFA7CF2-F1E6-4314-B71F-9C9654B2E5B4Q28476506-1EFE334E-8D67-4BA3-A698-601D86D6E9A4Q28539865-138518D3-C098-44F0-9D80-D40A92000EF1Q28545192-64F5B966-139C-49A2-B0B1-BA005AD7507EQ28551120-D1F1323E-138D-4134-8992-399D55CEC91AQ28654633-A6B7DE7B-2919-4957-838E-75FF48D4AC60Q28972437-D2EA4952-A864-498C-BD57-7347A912F6C1Q30234397-8EE050CE-999F-48F7-8461-B25C8C89D51CQ30417079-B1B1351D-A494-402F-8CFB-1E589EF13135Q30619558-CA08E562-F057-49C8-891E-59F48FD689F8Q30687588-15203D8B-EDBD-4E01-B556-D03A572D04E2Q30849379-C71F8DC8-256D-4A8E-B551-28A590EED120Q33437306-4668BF63-D7F3-4227-B6ED-29B159B8AAF9Q33718232-702369F7-BEF4-42ED-91E6-EB583364408CQ33761633-DDE953C1-EEE2-4EC9-9CC6-A55CBB95575AQ33820841-D686B51D-2070-4D1F-AE02-36C1AFAB728DQ33839384-CEEE7A75-90CA-479C-88A7-8653BAFA3C12Q33843405-6428754D-405E-4F82-A008-FDD7ED1B040BQ33854333-13961157-2083-4CCA-861E-FAD783AB71A5Q33992746-968DF86D-60A9-4E39-B0BD-1ABC844893A0Q34002205-C8C9C3FE-ABB6-463C-968C-B408601F2746Q34091036-C44C050E-308B-4366-B861-549EE8120058Q34207990-D210F527-9E66-4F21-9AA8-D2FAD31E2D3EQ34211490-0350CEFB-02C3-48F8-8AA2-FBFE0F3F96B7Q34272872-892D6762-CA53-4A6F-B96B-F7BF65EF4C27Q34354151-36BC7F7D-EFEE-4041-BE9A-2791B2E47291Q34432576-7986E7D4-FA54-4CED-9C43-C3951596D73FQ34977258-B77AE6B9-325B-4245-BA2A-435BD89790E8Q35028661-24B5520A-1E9E-4DF3-B630-0200B894259E
P2860
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Localized hypersensitivity and ...... stent: should we be cautious?
@ast
Localized hypersensitivity and ...... stent: should we be cautious?
@en
Localized hypersensitivity and ...... stent: should we be cautious?
@nl
type
label
Localized hypersensitivity and ...... stent: should we be cautious?
@ast
Localized hypersensitivity and ...... stent: should we be cautious?
@en
Localized hypersensitivity and ...... stent: should we be cautious?
@nl
prefLabel
Localized hypersensitivity and ...... stent: should we be cautious?
@ast
Localized hypersensitivity and ...... stent: should we be cautious?
@en
Localized hypersensitivity and ...... stent: should we be cautious?
@nl
P2093
P3181
P1433
P1476
Localized hypersensitivity and ...... stent: should we be cautious?
@en
P2093
Andrew Farb
Frank D Kolodgie
Giulio Guagliumi
Giuseppe Musumeci
Laurian Mihalcsik
Maurizio Tespili
Niccolo Grieco
Orazio Valsecchi
Renu Virmani
Teresio Motta
P3181
P356
10.1161/01.CIR.0000116202.41966.D4
P407
P577
2004-02-17T00:00:00Z